{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001708527","name":"ELUTIA INC.","summary":"Elutia Inc. develops proprietary drug-eluting biomatrix (DEB) products for surgical reconstruction. Key products include SimpliDerm (human acellular dermal matrix), cardiovascular repair products (ProxiCor, VasCure, Tyke), and next-generation pipeline products NXT-41 and NXT-41x. The company sold its CIED business (EluPro, CanGaroo) to Boston Scientific for up to $88 million in October 2025 and previously divested its Orthobiologics Business to Berkeley Biologics in November 2023.","people":[],"products":[{"name":"SimpliDerm","type":"hardware","description":"Human acellular dermal matrix (hADM) used in soft tissue reconstruction; primary product in Women's Health segment."},{"name":"ProxiCor","type":"hardware","description":"Cardiovascular repair biologic matrix product in the Cardiovascular segment."},{"name":"VasCure","type":"hardware","description":"Cardiovascular repair biologic matrix product in the Cardiovascular segment."},{"name":"Tyke","type":"hardware","description":"Cardiovascular repair biologic matrix product in the Cardiovascular segment."},{"name":"NXT-41","type":"platform","description":"Next-generation advanced biomatrix designed for consistent handling, incorporation, and scalable manufacturing in reconstructive surgery."},{"name":"NXT-41x","type":"platform","description":"Builds on NXT-41 by incorporating local antibiotic drug delivery for broad-spectrum antimicrobial protection post-surgery."},{"name":"EluPro","type":"hardware","description":"First antibiotic-eluting biologic matrix envelope for cardiac implantable electronic devices; sold to Boston Scientific in October 2025."},{"name":"CanGaroo","type":"hardware","description":"Biologic matrix envelope for cardiac implantable electronic devices; sold to Boston Scientific in October 2025."}],"partnerships":[{"partner_name":"Boston Scientific Corporation","partnership_type":"strategic","description":"Former commercial partner for EluPro and CanGaroo; acquired Elutia's CIED Business for up to $88 million in October 2025.","start_date":null}],"affiliations":[],"origin":{"leaf":"d7ba56eac5b21267e69dc06e740a11ba61f722ff6442f28a964e63b8b1bc2753","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"455c2d30535308852b7cd974b651cf77732dc72140e7ba707587e942426acc1d","parent":"a66f467b717c4fd34ae3a56da2971324caee77b823f05381af9479a2d6220fc7","source":"0001104659-26-027664","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":369,"hourly_limit":500,"remaining":131,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}